Synapse

← Paul M. Ridker

Papers by Paul M. Ridker

Page 6 · newest first

  1. How to translate clinical trial results into gain in healthy life expectancy for individual patientsBMJ · 2016
  2. Circulating N-Linked Glycoprotein Acetyls and Longitudinal Mortality RiskCirculation Research · 2016
  3. Genome-Wide Association Study for Incident Myocardial Infarction and Coronary Heart Disease in Prospective Cohort Studies: The CHARGE ConsortiumPLoS ONE · 2016
  4. Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?Circulation Research · 2016
  5. From C-Reactive Protein to Interleukin-6 to Interleukin-1Circulation Research · 2016
  6. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraineWOS · 2015
  7. Plasma proprotein convertase subtilisin/kexin type 9 levels and the risk of first cardiovascular eventsEuropean Heart Journal · 2015
  8. Identifying Novel Gene Variants in Coronary Artery Disease and Shared Genes With Several Cardiovascular Risk FactorsCirculation Research · 2015
  9. Atherogenic Lipoprotein Subfractions Determined by Ion Mobility and First Cardiovascular Events After Random Allocation to High-Intensity Statin or PlaceboCirculation · 2015
  10. Plasma Inflammatory Markers and the Risk of Developing Hypertension in MenJournal of the American Heart Association · 2015
  11. Association Between High‐Sensitivity C‐Reactive Protein and Total Stroke by Hypertensive Status Among MenJournal of the American Heart Association · 2015
  12. Differential Genetic Effects on Statin-Induced Changes Across Low-Density Lipoprotein–Related MeasuresCirculation Cardiovascular Genetics · 2015
  13. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWFBlood · 2015
  14. Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting StateClinical Chemistry · 2015
  15. Plasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysisCancer Epidemiology Biomarkers & Prevention · 2015
  16. Novel Protein Glycan Side-Chain Biomarker and Risk of Incident Type 2 Diabetes MellitusArteriosclerosis Thrombosis and Vascular Biology · 2015
  17. A Multivariate Genome-Wide Association Analysis of 10 LDL Subfractions, and Their Response to Statin Treatment, in 1868 CaucasiansPLoS ONE · 2015
  18. High-Sensitivity Cardiac Troponin I and B-Type Natriuretic Peptide as Predictors of Vascular Events in Primary PreventionCirculation · 2015
  19. The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trialsEuropean Heart Journal · 2015
  20. Prospective Study of Plasma Homocysteine Level and Risk of Age-Related Macular Degeneration in WomenOphthalmic Epidemiology · 2015
  21. Comparing Cardiovascular Risk Prediction ScoresAnnals of Internal Medicine · 2015
  22. No Evidence for Genome-Wide Interactions on Plasma Fibrinogen by Smoking, Alcohol Consumption and Body Mass Index: Results from Meta-Analyses of 80,607 SubjectsPLoS ONE · 2014
  23. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy womenHeart · 2014
  24. Is Venous Thromboembolism a Chronic Inflammatory Disease?Clinical Chemistry · 2014
  25. Statin Therapy and Risk of FractureJAMA Internal Medicine · 2014
  26. Cardiovascular risks associated with incident and prevalent periodontal diseaseJournal Of Clinical Periodontology · 2014
  27. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians2014
  28. Genetic loci associated with circulating levels of very long-chain saturated fatty acidsJournal of Lipid Research · 2014
  29. Genome wide association study identifies variants in NBEA associated with migraine in bipolar disorderJournal of Affective Disorders · 2014
  30. Further Insight Into the Cardiovascular Risk CalculatorJAMA Internal Medicine · 2014
  31. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trialsThe Lancet · 2014
  32. A Novel Protein Glycan Biomarker and Future Cardiovascular Disease EventsJournal of the American Heart Association · 2014
  33. Impact of sepsis on risk of postoperative arterial and venous thromboses: large prospective cohort studyBMJ · 2014
  34. Comparison of Lifestyle-Based and Traditional Cardiovascular Disease Prediction in a Multiethnic Cohort of Nonsmoking WomenCirculation · 2014
  35. Polymorphisms in Catechol- O -Methyltransferase Modify Treatment Effects of Aspirin on Risk of Cardiovascular DiseaseArteriosclerosis Thrombosis and Vascular Biology · 2014
  36. Effects of an Antisense Oligonucleotide Inhibitor of C‐Reactive Protein Synthesis on the Endotoxin Challenge Response in Healthy Human Male VolunteersJournal of the American Heart Association · 2014
  37. Plasma Levels of the Proinflammatory Chitin‐Binding Glycoprotein YKL‐40, Variation in the Chitinase 3‐Like 1 Gene ( CHI3L1 ), and Incident Cardiovascular EventsJournal of the American Heart Association · 2014
  38. Selectivity in Genetic Association with Sub-classified Migraine in WomenPLoS Genetics · 2014
  39. Association of cyclooxygenase-2 genetic variant with cardiovascular diseaseEuropean Heart Journal · 2014
  40. Predisposing Factors Associated With Development of Persistent Compared With Paroxysmal Atrial FibrillationJournal of the American Heart Association · 2014
  41. Plasma Pentraxin 3 Levels Do Not Predict Coronary Events but Reflect Metabolic Disorders in Patients with Coronary Artery Disease in the CARE TrialPLoS ONE · 2014
  42. Common Genetic Variations in the Vitamin D Pathway in Relation to Blood PressureAmerican Journal of Hypertension · 2014
  43. Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studiesBMJ · 2014
  44. Personalized cardiovascular disease prevention by applying individualized prediction of treatment effectsEuropean Heart Journal · 2014
  45. Complete blood count risk score and its components, including RDW, are associated with mortality in the JUPITER trialEuropean Journal of Preventive Cardiology · 2014
  46. Gene variations of ROCKs and risk of ischaemic stroke: the Women's Genome Health StudyClinical Science · 2013
  47. Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary EventsCirculation · 2013
  48. Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular RiskCirculation · 2013
  49. Targeting inflammatory pathways for the treatment of cardiovascular diseaseEuropean Heart Journal · 2013
  50. High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin TherapyCirculation · 2013